Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.

Loo C, Glozier N, Barton D, Baune BT, Mills NT, Fitzgerald P, Glue P, Sarma S, Galvez-Ortiz V, Hadzi-Pavlovic D, Alonzo A, Dong V, Martin D, Nikolin S, Mitchell PB, Berk M, Carter G, Hackett M, Leyden J, Hood S, Somogyi AA, Lapidus K, Stratton E, Gainsford K, Garg D, Thornton NLR, Fourrier C, Richardson K, Rozakis D, Scaria A, Mihalopoulos C, Chatterton ML, McDonald WM, Boyce P, Holtzheimer PE, Kozel FA, Riva-Posse P, Rodgers A

Open source

DOI
10.1192/bjp.2023.79
Published
2023 Dec
Container
The British journal of psychiatry : the journal of mental science
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1192/bjp.2023.79,
  title = {Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.},
  author = {Loo C and Glozier N and Barton D and Baune BT and Mills NT and Fitzgerald P and Glue P and Sarma S and Galvez-Ortiz V and Hadzi-Pavlovic D and Alonzo A and Dong V and Martin D and Nikolin S and Mitchell PB and Berk M and Carter G and Hackett M and Leyden J and Hood S and Somogyi AA and Lapidus K and Stratton E and Gainsford K and Garg D and Thornton NLR and Fourrier C and Richardson K and Rozakis D and Scaria A and Mihalopoulos C and Chatterton ML and McDonald WM and Boyce P and Holtzheimer PE and Kozel FA and Riva-Posse P and Rodgers A},
  year = {2023},
  journal = {The British journal of psychiatry : the journal of mental science},
  doi = {10.1192/bjp.2023.79},
  url = {https://doi.org/10.1192/bjp.2023.79}
}

RIS

TY  - JOUR
TI  - Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.
AU  - Loo C
AU  - Glozier N
AU  - Barton D
AU  - Baune BT
AU  - Mills NT
AU  - Fitzgerald P
AU  - Glue P
AU  - Sarma S
AU  - Galvez-Ortiz V
AU  - Hadzi-Pavlovic D
AU  - Alonzo A
AU  - Dong V
AU  - Martin D
AU  - Nikolin S
AU  - Mitchell PB
AU  - Berk M
AU  - Carter G
AU  - Hackett M
AU  - Leyden J
AU  - Hood S
AU  - Somogyi AA
AU  - Lapidus K
AU  - Stratton E
AU  - Gainsford K
AU  - Garg D
AU  - Thornton NLR
AU  - Fourrier C
AU  - Richardson K
AU  - Rozakis D
AU  - Scaria A
AU  - Mihalopoulos C
AU  - Chatterton ML
AU  - McDonald WM
AU  - Boyce P
AU  - Holtzheimer PE
AU  - Kozel FA
AU  - Riva-Posse P
AU  - Rodgers A
PY  - 2023
JO  - The British journal of psychiatry : the journal of mental science
DO  - 10.1192/bjp.2023.79
UR  - https://doi.org/10.1192/bjp.2023.79
ER  - 

APA

C, L., N, G., D, B., BT, B., NT, M., P, F., P, G., S, S., V, G., D, H., A, A., V, D., D, M., S, N., PB, M., M, B., G, C., M, H., J, L., S, H., AA, S., K, L., E, S., K, G., D, G., NLR, T., C, F., K, R., D, R., A, S., C, M., ML, C., WM, M., P, B., PE, H., FA, K., P, R., & A, R. (2023). Efficacy and safety of a 4-week course of repeated subcutaneous ketamine injections for treatment-resistant depression (KADS study): randomised double-blind active-controlled trial.. The British journal of psychiatry : the journal of mental science. https://doi.org/10.1192/bjp.2023.79

Source records